These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 16489018)

  • 1. Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors.
    Amin DN; Hida K; Bielenberg DR; Klagsbrun M
    Cancer Res; 2006 Feb; 66(4):2173-80. PubMed ID: 16489018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting EGFR activity in blood vessels is sufficient to inhibit tumor growth and is accompanied by an increase in VEGFR-2 dependence in tumor endothelial cells.
    Amin DN; Bielenberg DR; Lifshits E; Heymach JV; Klagsbrun M
    Microvasc Res; 2008 May; 76(1):15-22. PubMed ID: 18440031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic analysis of the epidermal growth factor (EGF) receptor-ErbB2-ErbB3 protein network by luciferase fragment complementation imaging.
    Macdonald-Obermann JL; Adak S; Landgraf R; Piwnica-Worms D; Pike LJ
    J Biol Chem; 2013 Oct; 288(42):30773-30784. PubMed ID: 24014028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
    Alimandi M; Wang LM; Bottaro D; Lee CC; Kuo A; Frankel M; Fedi P; Tang C; Lippman M; Pierce JH
    EMBO J; 1997 Sep; 16(18):5608-17. PubMed ID: 9312020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.
    Brockhoff G; Heiss P; Schlegel J; Hofstaedter F; Knuechel R
    Cytometry; 2001 Aug; 44(4):338-48. PubMed ID: 11500850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trophoblast subtype-specific EGFR/ERBB4 expression correlates with cell cycle progression and hyperplasia in complete hydatidiform moles.
    Fock V; Plessl K; Fuchs R; Dekan S; Milla SK; Haider S; Fiala C; Knöfler M; Pollheimer J
    Hum Reprod; 2015 Apr; 30(4):789-99. PubMed ID: 25740878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor (EGF) receptor kinase-independent signaling by EGF.
    Deb TB; Su L; Wong L; Bonvini E; Wells A; David M; Johnson GR
    J Biol Chem; 2001 May; 276(18):15554-60. PubMed ID: 11279155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of EGF growth factor ligands and their effects on cultured rat conjunctival goblet cell proliferation.
    Gu J; Chen L; Shatos MA; Rios JD; Gulati A; Hodges RR; Dartt DA
    Exp Eye Res; 2008 Feb; 86(2):322-34. PubMed ID: 18155194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners.
    Li Z; Mei Y; Liu X; Zhou M
    Cell Signal; 2007 Mar; 19(3):466-71. PubMed ID: 16978839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ErbB3 inhibitory surrobodies inhibit tumor cell proliferation in vitro and in vivo.
    Foreman PK; Gore M; Kobel PA; Xu L; Yee H; Hannum C; Ho H; Wang SM; Tran HV; Horowitz M; Horowitz L; Bhatt RR
    Mol Cancer Ther; 2012 Jul; 11(7):1411-20. PubMed ID: 22553357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition.
    Clark PA; Iida M; Treisman DM; Kalluri H; Ezhilan S; Zorniak M; Wheeler DL; Kuo JS
    Neoplasia; 2012 May; 14(5):420-8. PubMed ID: 22745588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2.
    Esparís-Ogando A; Díaz-Rodríguez E; Montero JC; Yuste L; Crespo P; Pandiella A
    Mol Cell Biol; 2002 Jan; 22(1):270-85. PubMed ID: 11739740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C Virus Activates a Neuregulin-Driven Circuit to Modify Surface Expression of Growth Factor Receptors of the ErbB Family.
    Stindt S; Cebula P; Albrecht U; Keitel V; Schulte am Esch J; Knoefel WT; Bartenschlager R; Häussinger D; Bode JG
    PLoS One; 2016; 11(2):e0148711. PubMed ID: 26886748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ErbB3 expression and dimerization with EGFR influence pancreatic cancer cell sensitivity to erlotinib.
    Frolov A; Schuller K; Tzeng CW; Cannon EE; Ku BC; Howard JH; Vickers SM; Heslin MJ; Buchsbaum DJ; Arnoletti JP
    Cancer Biol Ther; 2007 Apr; 6(4):548-54. PubMed ID: 17457047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BB, a new EGFR inhibitor, exhibits prominent anti-angiogenesis and antitumor activities.
    Sun QM; Miao ZH; Lin LP; Gui M; Zhu CH; Xie H; Duan WH; Ding J
    Cancer Biol Ther; 2009 Sep; 8(17):1640-7. PubMed ID: 19625781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor.
    Soltoff SP; Carraway KL; Prigent SA; Gullick WG; Cantley LC
    Mol Cell Biol; 1994 Jun; 14(6):3550-8. PubMed ID: 7515147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ErbB receptors mediate both migratory and proliferative activities in human melanocytes and melanoma cells.
    Gordon-Thomson C; Jones J; Mason RS; Moore GP
    Melanoma Res; 2005 Feb; 15(1):21-8. PubMed ID: 15714117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of epidermal growth factor (EGF)/transforming growth factor-alpha by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of mice.
    Wu W; O'Reilly MS; Langley RR; Tsan RZ; Baker CH; Bekele N; Tang XM; Onn A; Fidler IJ; Herbst RS
    Mol Cancer Ther; 2007 Oct; 6(10):2652-63. PubMed ID: 17913856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal transduction by epidermal growth factor and heregulin via the kinase-deficient ErbB3 protein.
    Kim HH; Vijapurkar U; Hellyer NJ; Bravo D; Koland JG
    Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):189-95. PubMed ID: 9693119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.